Covered recipient · General Payments record
TARIK A ALI
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$785.48
- Reported across 34 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $257.61 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $178.49 | 6 |
| Acerta Pharma LLC | $41.23 | 2 |
| Medtronic, Inc. | $23.31 | 1 |
| Lilly USA, LLC | $14.58 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $18.35 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105534054 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.88 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105776934 | CMS |
| GlaxoSmithKline, LLC. | $14.64 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115887802 | CMS |
| GlaxoSmithKline, LLC. | $7.48 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116731500 | CMS |
| GlaxoSmithKline, LLC. | $7.00 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115842677 | CMS |
| GlaxoSmithKline, LLC. | $124.74 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116584897 | CMS |
| GlaxoSmithKline, LLC. | $14.96 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116619369 | CMS |
| GlaxoSmithKline, LLC. | $9.67 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115976999 | CMS |
| Lilly USA, LLC | $14.58 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135437035 | CMS |
| Medtronic, Inc. | $23.31 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119334735 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.